Infection of baboons with herpesvirus papio 2 (HVP-2) produces a disease that is similar to human infection with herpes simplex viruses (HSV). Molecular characterization of HVP-2 has demonstrated that the virion contains a factor which rapidly shuts off host cell protein synthesis after infection. Reduction of host cell protein synthesis occurs in parallel with the degradation of mRNA species. A homolog of the HSV virion host shutoff (vhs) gene was identified by Southern and DNA sequence analysis. The sequence of the HVP-2 vhs gene homolog had greater than 70% identity with the vhs genes of HSV 1 and 2. Disruption of the HVP-2 vhs open reading frame diminished the ability of the virus to shut off protein synthesis and degrade cellular mRNA, indicating that this gene was responsible for the vhs activity. The HVP-2 model system provides the opportunity to study the biological role of vhs in the context of a natural primate host. Further development of this system will provide a platform for proof-of-concept studies that will test the efficacy of vaccines that utilize vhs-deficient viruses. 
INTRODUCTION
Herpesvirus papio 2 (HVP-2) infection of baboons represents a surrogate primate model system to study the biology of herpes simplex virus (HSV) infection of humans. HVP-2 is associated with oral and genital lesions that resemble HSV infections of humans. Male baboons develop erythema of the penis with papules or pustules that develop into small ulcerative lesions. Female baboons have been observed with ulcerative lesions on the vulvar tissues. Juvenile animals were found to have primarily oral lesions (Levin et al., 1988) . Acquisition of genital infection is primarily associated with the onset of sexual activity in baboons. Furthermore, one study provided evidence that the virus could spontaneously reactivate from latency, a pattern consistent with HSV infection of humans (Martino et al., 1998) .
Early attempts to characterize virus isolated from infected baboons resulted in designation of the virus as SA8, a virus first isolated from African green monkeys (Levin et al., 1988) . Subsequent analysis of three viral glycoprotein genes (glycoproteins B, D, and J) confirmed that the herpesvirus associated with the baboon disease was closely related to other members of the alphaherpesvirus family (HSV-1, HSV-2, herpes B virus). Although closely related, the isolates represented a new virus associated with baboons, which was designated as herpesvirus papio 2 (HVP-2) (Eberle et al., 1995) . Subsequent serological analysis has determined that over 90% of wild-caught baboons were found to have anti-HVP-2 titers, confirming that baboons are a natural host for HVP-2 (Eberle et al., 1997) .
A hallmark of alphaherpesvirus infection is the shutoff of host protein synthesis during infection (Fenwick, 1984) . Shutoff of host macromolecular synthesis occurs through two independent mechanisms in HSV-infected cells. Early phase shutoff is mediated by a 58-kDa phosphoprotein encoded by the viral UL41 gene designated the virion host shutoff (vhs) protein (Read and Frenkel, 1983; Kwong et al., 1988 , McGeoch et al., 1988 Read et al., 1993) . During infection, the virion tegument (containing vhs) is released into the cytoplasm of the host cell. Cytoplasmic vhs is associated with the degradation of mRNA (Schek and Bachenheimer, 1985; Kwong and Frenkel, 1987; Strom and Frenkel, 1987; Oroskar and Read, 1989) . Degradation of cellular mRNA shifts the translation apparatus from host to viral mRNA and facilitates the expression of different classes of viral genes. A secondary phase shutoff is dependent on the immediateearly protein ICP27 (Nishioka and Silverstein, 1978; Fenwick and Clark, 1982; McMahan and Schaffer, 1990; Hardwicke and Sandri-Goldin, 1999) .
The exact mechanism of vhs activity has not been determined. Several studies have suggested that vhs is an endonuclease. First, cytoplasmic extracts prepared from HSV-infected cells or extracts prepared from HSV virions contain a vhs-dependent RNase activity (Krikorian and Read, 1991; Sorenson et al., 1991; Karr and Read, 1999; Zelus et al., 1996) . Second, vhs induces cleavage of mRNAs when expressed as the only viral protein in a rabbit reticulolysate system (Zelus et al., 1996; Elgadi et al., 1999a,b) . Antibodies to vhs protein block endo-ribonucleolytic activity in vitro (Zelus et al., 1996) . Finally, vhs has homology to the fen-1 family of endonucleases (Doherty et al., 1996) . In vitro studies have shown that vhs induces endonucleolytic cleavages which cluster toward the 5Ј end of the mRNA (Zelus et al., 1996; Karr and Read, 1999; Elgadi et al., 1999a,b) . Interestingly, a recent study by Lu and co-workers (2001a) using a mutant vhs has demonstrated that the protein may direct initial cleavage events and play a role in degradation of mRNA containing IRES elements.
Two studies have demonstrated the potential role of cellular factors in vhs function. Expression of vhs in Saccaromyces cerevisiae did not result in any vhs-dependent endoribonuclease activity (Lu et al., 2001b) . However, activity was detected when the yeast extracts were mixed with rabbit reticulocyte lysates. These studies indicated that vhs function is dependent on one or more mammalian factors. In a second study, Feng and co-workers (2001) demonstrated that vhs bound to the human translation initiation factor, eIF4H, in both twohybrid and co-immunoprecipitation assays. The results of these studies suggest that vhs is targeted to regions of translation initiation through interaction with eIF4H.
Several studies using the mouse model of infection have demonstrated that vhs is an important virulence factor. For example, Becker and co-workers (1993) demonstrated that vhs-defective viruses lack intraperitoneal pathogenicity in newborn mice. Strelow and Leib (1995) demonstrated that vhs-defective viruses did not grow efficiently in mouse cornea and brains. Furthermore, vhs-deficient viruses are not efficient at establishment and reactivation from latency in mouse trigeminal ganglia. The attenuated virulence associated with vhs-deficient viruses makes them attractive vaccine candidates. Interestingly, mice immunized with an HSV-1 strain deficient in vhs activity are protected against corneal challenge with virulent HSV-1 in a mouse model of infection (Walker et al., 1998) . These studies have been further extended in the mouse model to show the enhanced protection against wild-type HSV challenge in animals vaccinated with a recombinant HSV-1 with deletions in both vhs and ICP8 (Geiss et al., 2000) .
To develop the HVP-2 model system, we have initiated a careful comparison of the molecular biology of this virus relative to human simplex viruses. The results of the studies presented here have demonstrated that HVP-2 encodes a virion host shutoff function that is closely related to the vhs encoded by HSV-1. These studies further demonstrate the close molecular relationship between HVP-2 and HSV. The HVP-2 model provides a surrogate system to complement and extend our understanding of the biology of vhs. Future studies can test the efficacy of vhs-deficient virus vaccines in the context of a nonhuman primate system.
RESULTS

HVP-2 infection results in a shutoff of host protein synthesis
The reduction of host cell protein synthesis is a hallmark of herpes simplex virus infection (Fenwick, 1984) . To determine whether host protein synthesis is reduced during HVP-2 infection, [
35 S]methionine-labeled extracts from infected and mock-infected Vero cells were prepared at varying times postinfection and analyzed on denaturing polyacrylamide gels. Comparison of mockand virus-infected extracts revealed that HVP-2 infection resulted in a dramatic reduction in host cell protein synthesis as early as 2 h postinfection (Fig. 1A) . Host cell protein synthesis was further reduced at 3 and 4 h postinfection. The appearance of several new protein species is likely due to the expression of viral genes as addition of actinomycin D blocks the appearance of these bands (data not shown). The inhibition of host protein synthesis early in HVP-2 infection is similar to the reduction of protein synthesis observed in HSV-1-infected cells (Fig. 1A) .
To determine the species-specificity of the HVP-2 protein shutoff function, [
35 S]methionine-labeled extracts were prepared from baboon, human, and mouse cell lines 4 h postinfection. Extracts were separated on denaturing polyacrylamide gels and visualized by autoradiography. Examination of the autoradiograms demonstrated that there was a reduction in host cell protein synthesis in primary baboon fibroblasts, HepG2, and NIH 3T3 cells (Fig. 1B) . The observation that HVP-2 induced a shutoff of host cell protein synthesis in primary baboon fibroblasts demonstrates that this process occurs in cells isolated from the natural host. Therefore, shutoff is a process that is likely to occur during natural infection and is not the result of an artifact of Vero cell infection. Shutoff of host protein synthesis was also observed in human liver cells (HepG2) and mouse fibroblasts (NIH3T3). Therefore, the HVP-2 host shutoff function is active in cell types from different species. This observation indicates that the shutoff of host protein synthesis by HVP-2 is likely to proceed by a conserved mechanism that can function in cells from a variety of species.
Shutoff of protein synthesis is associated with the HVP-2 virion
The decrease in host cell protein synthesis during HVP-2 infection could be due to the action of a nascent viral protein(s), the activity of an induced or activated cellular protein, or the direct action of a virion protein. effective, equivalent amounts of extracts from mock and treated cells were resolved on 4-20% SDS-PAGE gels and visualized by autoradiography. The results demonstrated that the protein species remained comigrated with cellular proteins in mock-treated cells and that there was an absence of proteins that typically appear early during viral infection (data not shown). Therefore, active levels of viral gene expression are effectively blocked by actinomycin D. Inhibition of protein synthesis in the absence of active transcription indicates that synthesis of viral gene products is not required for shutoff of host protein synthesis. Rather, the shutoff activity is brought in by the infecting virus and is therefore virion-associated. Furthermore, the magnitude of the decrease in protein synthesis was related to the amount of input virus, i.e., the phenomenon was m.o.i. dependent. These results indicate that inhibition of host protein synthesis is the result of a factor that is delivered by the HVP-2 virion and is not the result of the expression of viral genes. Taken together, these results clearly demonstrate that HVP-2 contains a virion host shutoff function.
HVP-2 infection induces degradation of host mRNA
Infection of cells with HSV-1 has been shown to induce the degradation of mRNA in a vhs-dependent manner (Kwong and Frenkel, 1987; Oroskar and Read, 1989) . To determine whether HVP-2 infection induces degradation of host cell mRNA, total RNA was isolated from infected and mock-infected Vero cells 4 h postinfection. The levels of specific mRNAs were determined by Northern blot analysis using probes for mouse glyceraldehyde phosphate dehydrogenase (GAPDH) and mouse ␤-actin. The results of these studies are shown in Fig. 1D . Equivalent amounts of RNA were loaded as demonstrated by the levels of 28S RNA in ethidium bromide stained gels. In the case of both GAPDH and ␤-actin probes, the level of message present at 0.1 m.o.i. was similar to the level of message present in mock-infected cells. However, as the multiplicity of infection was increased to 1.0 and 10, there was a corresponding decrease in the level of message for both GAPDH and ␤-actin. The levels of the respective RNA species were quantitated by phosphorImager analysis. A 10 m.o.i. infection with HVP-2 resulted in a reduction of GAPDH message to levels of only 20% of the mock-infected samples, while ␤-actin was reduced to levels of approximately 10% of the mockinfected samples. Therefore, infection of cells with HVP-2 results in a dose-dependent degradation of host cell mRNA species, a phenomenon associated with vhs function in HSV-infected cells.
The HVP-2 genome contains a UL41 homolog
The results of protein synthesis and Northern blot analysis indicate that HVP-2 may contain a homolog of the HSV-1 UL41 gene that encodes the vhs protein. The physical map of the HVP-2 genome is colinear with HSV (J. E. Bigger and D. W. Martin, unpublished data). DNA sequence analysis of the ends of a 4-kilobase (kb) BamHI fragment of HVP-2 strain 860 cloned into pUC19 (pBam20) showed homology to genes that flank UL41, the HSV genes UL40 and UL42. The entire clone was sequenced on both DNA strands. BLAST analysis (GenBank) of the resulting DNA sequence revealed that HVP-2 contains a HSV-1 UL41 (vhs gene) homolog. The sequence of this gene has been deposited in GenBank (Accession No. AF294581). The open reading frame contains 481 amino acids and would encode a protein with a calculated molecular weight of 54,216 Da. Figure 2 shows the amino acid sequence of the HVP-2 vhs homolog relative to proteins from HSV-1 strain KOS and HSV-2 strain 333. HVP-2 vhs shows greater than 70% similarity with the vhs proteins of HSV-1 and HSV-2. Previous analyses of the sequences of vhs homologs from several different alphaherpesviruses have revealed the existence of four conserved domains across the vhs protein (Berthomme et al., 1993) . These domains are well conserved within the HVP-2 vhs homolog. Phylogenetic analysis of the HVP-2 vhs relative to vhs homologs of other alphaherpesviruses demonstrates that the HVP-2 homolog is most closely related to the vhs proteins of HSV (Fig. 3) . The close relationship between the vhs genes of HVP-2 and HSV is consistent with previous studies that demonstrated that HVP-2 is closely related to HSV (Eberle et al., 1995) .
Disruption of the HVP-2 UL41 homolog
A recombinant virus with a disruption in the HVP-2 vhs gene was constructed to determine whether the vhs homolog is responsible for the modulation of protein synthesis in infected cells. The pBam20 clone contains portions of the UL40 and UL42 open reading frames (ORF) as well as an intact UL41 ORF (Fig. 4) . A reporter gene cassette was constructed that placed the enhanced green fluorescent protein (EGFP) gene under control of the CMV immediate early promoter. This cassette was cloned into the unique Bsu36I site of pBam20 to generate pBam20-EGFP. The resulting construct had an insertion of the reporter gene cassette 60 nucleotides from the amino-terminal end of the UL41 open reading frame, thereby interrupting the vhs protein between the alanine and leucine residues at positions 20 and 21. The pBam20-EGFP insert was transferred into the HVP-2 vhs gene by marker transfer. EGFP-expressing plaques were purified three times and the recombinant, HVP-2⌬vhs, was grown to high titers and analyzed to confirm the vhs deletion. HVP-2⌬vhs was subsequently rescued by marker transfer with pBam20, a plasmid that contains a region of the HVP-2 genome that spans the vhs gene. The rescue virus is designated HVP-2⌬vhsR.
The structure of the recombinant virus was confirmed by Southern blot analysis of viral DNA isolated from wild-type HVP-2, HVP-2⌬vhs, and HVP-2⌬vhsR. A schematic of the vhs locus is shown in Fig. 4A . The presence of the EGFP insert in HVP-2⌬vhs was confirmed by Southern analysis of BamHI-cut DNA hybridized with the EGFP gene as a probe (Fig. 4B ). As expected, neither wild-type HVP-2 or HVP-2⌬vhsR demonstrated any hybridization to the EGFP probe. The vhs locus was visible as a 4.1-kb BamHI fragment in wild-type HVP-2 and HVP-2⌬vhsR DNA by Southern analysis using pBam20 as a probe (Fig. 4B) . In contrast, digestion of HVP-2⌬vhs with BamHI demonstrated that the vhs locus is disrupted due to a BamHI site donated by the reporter gene cassette, resulting in the generation of 4-and 2.2-kb BamHI bands (Fig. 4B) . Taken together, the results of the Southern analysis indicate the vhs gene has been successfully interrupted in HVP-2⌬vhs and successfully restored in HVP-2⌬vhsR.
HVP-2 vhs activity is not required for in vitro replication
The results of several experiments demonstrated that the product of the HVP-2 vhs gene is not required for in vitro replication. First, the ability to construct HVP-2⌬vhs in a noncomplementing cell line indicates that this viral gene is dispensable for growth in vitro. Both wild-type and mutant viruses generate a vigorous plaque after 3 days. However, the morphology of the plaques generated by HVP-2⌬vhs differed from the plaques produced by wild-type HVP-2 and HVP-2⌬vhsR on Vero cells (not shown). Plaques generated by wild-type HVP-2 and HVP2⌬vhsR on Vero cells do not typically show a clear area in the center. In contrast, plaques generated by HVP-2⌬vhs demonstrate greater cell rounding in the center of the plaque which leads to a larger area in the center of the plaque where cells have detached from the surface. Second, a plaque yield assay was performed to compare the relative replication rates between wild-type HVP-2 and HVP-2⌬vhs. This assay measures the burst size or number of plaque forming units released per plaque. The results in both Vero cells and primary baboon fibroblasts demonstrated that disruption of the vhs locus results in a nearly 2 log reduction in viral replication (data not shown).
Finally, a single-step growth curve was performed to quantitate the growth of the HVP-2⌬vhs relative to wildtype HVP-2. Previous studies have determined that the HVP-2 growth cycle occurs in approximately 18 h (J. E. Bigger and D. W. Martin, unpublished data). Vero cells were infected at a m.o.i. of 2 in duplicate with wild-type HVP-2, HVP-2⌬vhs, or HVP-2⌬vhsR and harvested at varying times postinfection. Infected cells were disrupted by successive freeze-thaw cycles and the levels of infectious virus in the supernatants were determined by plaque analysis. The results of this analysis demonstrated that HVP-2⌬vhs replicated with slightly delayed kinetics relative to wild-type virus (Fig. 5) . Comparison of the replication curves revealed that maximal levels of HVP-2⌬vhs were approximately 1 log lower than wildtype virus at 20 h postinfection. Interestingly, the replication of HVP-2⌬vhsR displayed an intermediate pattern of replication. Although this virus replicated better than HVP-2⌬vhs at 20 h postinfection, the rescue virus did not replicate as well as the wild-type isolate. We hypothesize that the difference in replication may be due to the effect of multiple rounds of replication acquired during generation of the knock-out and rescue virus in Vero cells relative to the original, low-passage wild-type isolate. Future studies that involve the disruption and rescue of other HVP-2 gene products will isolate wild-type plaques in parallel with recombinant viruses to compare the replication of viruses subjected to equivalent rounds of in vitro replication. Taken together, these studies demonstrate that although the vhs gene is dispensable for HVP-2 replication in vitro, optimal replication requires the presence of functional HVP-2 vhs. Future studies will test the role of the HVP-2 vhs gene during in vivo infection. In vivo studies will require the use of a vhs knock-out virus that contains a small mutagenesis cassette to avoid any variables imposed by a large mutagenesis cassette that encodes a reporter gene.
The HVP-2 UL41 homolog encodes vhs activity
To determine whether disruption of the HVP-2 vhs locus affects the shutoff of host cell protein synthesis, infected cells were transiently labeled with [
35 S]methionine and the extracts were analyzed by SDS-PAGE. The results of this assay are shown in Fig. 6A . Infection with wild-type HVP-2 results in a significant decrease in host cell protein synthesis at 4 h postinfection when compared to the mock-infected samples. Infection with HVP2⌬vhs did not result in a significant level of shutoff of host cell protein synthesis. The slight reduction observed is most likely the result of the simple competition of viral and cellular messages for the translation apparatus. However, the overall distribution of protein synthesis is very similar to that observed in mock-infected cells. Interestingly, the pattern of protein synthesis in HVP2⌬vhsR was identical to the pattern observed in cells infected with wild-type HVP-2. Therefore, the HVP-2 vhs gene is required for efficient shutoff of host cell protein synthesis. We have shown earlier that infection of cells with wild-type HVP-2 induces the degradation of host cell mRNA (Fig. 1D) . Therefore, Northern analysis was performed to determine whether the HVP-2 vhs gene product was responsible for the decrease in levels of cellular mRNA. Total RNA was isolated from cells infected with wild-type HVP-2, HVP-2⌬vhs, HVP-2⌬vhsR, or mock-infected cells and analyzed to determine the relative levels of GAPDH and ␤-actin messages by Northern analysis (Fig. 6B) . Infection with both wild-type HVP-2 and HVP2⌬vhsR resulted in a significant reduction in the levels of both ␤-actin and GAPDH mRNA. In contrast, infection with HVP-2⌬vhs did not cause a significant reduction in the levels of mRNA and the general levels were similar to the signals observed in mock-infected cells (Fig. 6B) . Quantitation by phosphorImager analysis revealed that infection with wild-type HVP-2 and HVP-2⌬vhsR reduced the ␤-actin mRNA levels to 23 and 10% of mock-infected levels, respectively. In addition, the GAPDH mRNA levels were reduced to 12 and 19% the levels of observed in mock-infected cells. In contrast, cells infected with HVP2⌬vhs maintained high levels of ␤-actin mRNA (95%) and GAPDH mRNA (81%) relative to the levels found in mockinfected cells. Therefore, these results clearly demonstrate that the vhs gene is clearly required for both the shutoff of host protein synthesis and the reduction in host mRNA levels.
DISCUSSION
The results of these studies have demonstrated that HVP-2 encodes a virion host shutoff function. First, infection of cells with HVP-2 resulted in a decrease in host cell protein synthesis. In addition, the shutoff activity was associated with the HVP-2 virion. Second, the decrease in host protein synthesis was accompanied by degradation of cellular mRNA. Third, analysis of the HVP-2 genome revealed a homolog of the HSV UL41 (vhs) gene. The HVP-2 homolog maintains greater than 70% homology with the UL41 genes from HSV. Finally, a recombi- Northern analysis of total RNA extracted from Vero cells infected with wild-type virus, HVP-2⌬vhs, HVP-2⌬vhsR, or mock-infected 4 h postinfection. Levels of total RNA were determined by ethidium bromide staining to visualize 28S RNA. mRNA was detected using mouse probes against ␤-actin and GAPDH. Note that disruption of the vhs gene reading frame results near wildtype levels of mRNA and that restoration of the wild-type vhs locus in HVP-2⌬vhsR results in a reduction of host mRNA as seen in cells infected with wild-type HVP-2.
nant virus with a disruption in the HVP-2 vhs gene lost the ability to shut off host protein synthesis and degrade cellular mRNA. Subsequent marker transfer of a wildtype locus back into the virus restored the ability of the virus to mediate shutoff of host protein synthesis. The vhs gene was dispensable for in vitro replication, although levels of virus were reduced relative to wild-type HVP-2. Taken together, these results demonstrate that HVP-2 encodes a virion host shutoff function that is closely related to the vhs protein encoded by HSV.
The identification of an HVP-2 vhs homolog is significant for several reasons. First, characterization of the vhs gene of HVP-2 provides further evidence of the close molecular relationship between HVP-2 and the human simplex viruses. Second, the identification of a closely related vhs gene in HVP-2 provides a surrogate primate system to study the in vitro and in vivo biology of vhs. Finally, the identification of a vhs homolog in HVP-2 will provide a proof-of-concept platform allowing for the further development of vhs-deficient viruses for use in vaccine therapy. The use of a relevant surrogate primate model to test the efficacy of these novel vaccines strategies should refine the development of these strategies and extend the results from small animal models of HSV infection.
The predicted reading frame of the HVP-2 vhs homolog maintains greater than 70% identity with HSV vhs. Berthomme et al. (1993) identified four domains of vhs that were highly conserved among alphaherpesviruses. These four domains are well conserved in HVP-2 vhs (Fig. 2) . Most cases of divergence within these domains represent conservative changes. Everly and Read (1999) , using point mutations of HSV-1 vhs/HSV-2 vhs chimeras, identified a number of residues of HSV-2 vhs (namely, R19, R22, E25, A396, and S423), which when placed individually into the HSV 1 vhs background would enhance vhs activity. HVP-2 vhs maintains conservation with HSV-2 vhs at each of these residues with the exception of positions 25 and 423. HVP-2 vhs substitutes alanine at position 25 (which is conserved with HSV-1 vhs) and an alanine at position 423. Finally, the sequence conservation between HVP-2 and HSV vhs proteins suggests that the protein-protein interactions observed with HSV-1 vhs may be conserved in the HVP-2 system. For example, HSV-1 vhs has been shown to interact with VP16 (Smibert et al., 1994) . Presumably, this interaction modulates vhs activity during late times of infection. We have previously identified a VP16 homolog in HVP-2 (GenBank Accession No. AF294740). Although this product has not yet been characterized, it will be interesting to determine whether the HVP-2 vhs interacts with HVP-2 VP16. The domain where HSV-1 vhs interacts with VP16 has been mapped to amino acids 310-330 (Schmelter et al., 1996) . Interestingly, the homologous domain in HVP-2 vhs (HVP-2 vhs amino acids 294-314) is relatively well conserved and maintains a tryptophan residue critical for HSV vhs:VP16 interaction. These similarities, coupled with the high degree of identity between the HVP-2 VP16 and HSV VP16 proteins (J. E. Bigger and D. W. Martin, unpublished data), suggest that the HVP-2 vhs may interact with VP16 as well. In addition, recent studies by Feng and co-workers (2001) have demonstrated that HSV-1 vhs interacts with eIF4H. Presumably, the interaction of vhs with eIF4H targets vhs to regions of translation initiation. Future studies will test the hypothesis that HVP-2 vhs interacts with eIF4H and VP16.
The importance of the vhs protein for the pathogenesis of the virus has been underscored by a series of studies on the virulence of HSV deficient for vhs function (Becker et al., 1993; Strelow and Leib, 1995; Strelow et al., 1997; Smith et al., 2000 Smith et al., , 2002 . Basically, these studies have shown that deletion of vhs function attenuates viral infection and latency in small animal models of disease presumably due to altered patterns of viral gene expression. vhs is also likely to play an important role in viral evasion of the host immune response. Evidence for this role in immune evasion has been provided by several studies. First, vhs function has been associated with a reduction in host cell MHC class I expression which would be expected to result in a lower degree of presentation of viral antigen to the immune system (Hill et al., 1994) . The vhs protein of bovine herpes virus 1 has also been associated with the down-regulation of MHC class I in infected cells (Koppers-Lalic et al., 2001) . Second, the vhs protein of HSV-2 has been shown to inhibit the activity of CD8 ϩ CTL clones against HSV-2-infected fibroblasts (Tigges et al., 1996) . Third, using ␥-irradiated mice, Suzutani and co-workers (2000) demonstrated that vhs function could inhibit the innate immune response. Interestingly, deletion of the vhs gene improves the immunogenicity of a replication-incompetent vaccine strain (Geiss et al., 2000) . Presumably, increased levels of viral gene products coupled with enhanced antigen presentation provide more target antigen to the host immune system. Taken together, it is likely that an additional function of vhs is to modulate the host immune response to infection. Future studies are planned to assess the role of HVP-2 vhs in immune evasion in a primate host.
The potential role of vhs in immune evasion makes vhs-deficient viruses attractive candidates for vaccine development. Furthermore, vhs-deficient viruses demonstrate low levels of pathogenicity in mouse models and do not establish or reactivate from latency efficiently Leib, 1995, 1997) . Interestingly, a vaccine strategy that employed a replication-defective virus with a deletion in ICP8 demonstrated greater levels of efficacy when an additional mutation was introduced to make the virus vhs-deficient (Geiss et al., 2000) . We have identified a ICP8 homolog in HVP-2 (J. E. Bigger and D. W. Martin, unpublished data). Deletion of this gene in the context of our vhs-deficient virus would make an attractive candidate to study the efficacy of this vaccine strategy in the context of a primate host. The results of these studies may further demonstrate that vhs-deficient viruses represent effective vaccine strategies and lead to future human trials.
MATERIALS AND METHODS
Cells and virus
Vero and NIH3T3 cells were obtained from the American Type Culture Collection and maintained in Dulbecco's modified essential medium (DMEM) (GIBCO Life Technologies, Rockville, MD) supplemented with 10% fetal bovine serum (FBS) (Hyclone) and penicillin and streptomycin. Primary baboon fibroblasts were obtained by skin punch biopsy of baboons (Papio anubis) at Southwest Foundation for Biomedical Research under strict animal welfare standards. Briefly, skin punches Ͻ 1 cm 2 were trypsinized to release fibroblasts from the tissue matrix and the cells were plated in DMEM with 10% FBS. Aliquots of low passage cells were frozen at Ϫ130°C. Cells used to detect vhs activity were used at Ͻ20 passages. HVP-2 strain 860 was obtained from R. Eberle, Oklahoma State University, Stillwater, OK. HSV-1 KOS and HVP-2 were propagated and titered on Vero cells.
Protein analysis
Cells were infected or mock-infected in duplicate at varying m.o.i. in DMEM with 10% FCS. One hour before harvesting, monolayers were washed with minimal essential medium (MEM) without methionine or cysteine (Selectamine, GIBCO). Cultures were then incubated in MEM (methionine-and cysteine-free) containing 0.1 Ci/ml EasyTag Express protein labeling mix ([ 35 S]-methionine and -cysteine, NEN Life Science Products, Boston, MA). For SDS-PAGE analysis, cells were lysed directly with Tris-glycine sample buffer (Novex) containing 2-mercaptoethanol and heated at 100°C for 5 min. Equivalent amounts of extract were run on 4-20% Tris-glycine gels (Novex). The levels of protein synthesis were visualized by autoradiography. To determine the role of the virion in vhs function, Vero cells were treated with 40 g/ml actinomycin D (Sigma) to inhibit transcription during the course of the infection. To quantitate the amount of labeled protein, duplicate infected and mock-infected samples were scraped into phosphate-buffered saline (PBS) and subjected to three freeze-thaw samples from Ϫ70°C to 37°C. Equivalent amounts of extract were precipitated with 10% trichloroacetic acid (TCA) in the presence of 100 g/ml bovine serum albumin (BSA). Acid precipitable counts were collected by filtration through 0.45-m glass wool filters and quantitated by liquid scintillation counting.
Northern analysis
Vero cells were infected or mock-infected at varying m.o.i. for 4 h. RNA was isolated using the RNeasy miniprep (Qiagen, Valencia, CA) and quantitated on a DU-68 spectrophotometer (Beckman). Two to four micrograms of RNA were resolved by formaldehyde-agarose gel electrophoresis and Northern blotted using materials from the NorthenMax blotting system (Ambion, Austin, TX). Blots were hybridized with random-prime labeled mouse ␤-actin or GAPDH (Ambion). The level of specific message was determined by autoradiography and quantitated by phosphorImager analysis (Molecular Dynamics phosphorImager 445SI).
Sequence alignments
Sequence alignments and phylogenetic tree were conducted using the Megalign program (DNAStar, Madison, WI). A phylogenetic tree was constructed using the Clustal method of alignment with PAM250 residue weight table. Accession numbers of protein sequences from GenBank are as follows: HSV-1 KOS (AF007815), HSV-2 strain 333 (AF007816), BHV-1. 1 (AJ004801), EHV-1 (M86664), PrV (S57917), GHV-2 (L40429), GHV-1 (AF168792), VZV strain Dumas (P09275), and HVP-2 strain 860 (AAG01880).
Generation of HVP-2⌬vhs and HVP-2⌬vhsR
Disruption of the HVP-2 vhs gene was accomplished by marker transfer. Briefly, the HVP-2 UL41 (vhs) homolog was isolated on a 4-kb BamHI clone (pBam20). The gene encoding the EGFP from the vector pEGFP-N1 (Clontech) was cloned by PCR downstream of the human cytomegalovirus (CMV) immediate-early promoter in the pCI expression vector (Promega, Madison, WI) using the restriction sites NheI and EcoRI to generate pCI-EGFP. The CMV-EGFP was PCR amplified using primers containing Bsu36I restriction sites at the termini so that the product could be cloned into the unique Bsu36I restriction site of pBam20 to generate pBam20-EGFP. The insertion of this fragment into the vhs gene interrupts the vhs open reading frame 60 nucleotides from the amino-terminal end of the UL41 open reading frame, thereby interrupting the vhs protein between the alanine and leucine residues at positions 20 and 21. pBam20-EGFP was transfected with wild-type HVP-2 strain 860 DNA into Vero cells. Recombinant virus plaques were selected by EGFP expression under fluorescent microscopy. The virus was plaque purified three times. Virus stocks were prepared by low multiplicity of infection passage on Vero cells. Marker transfer was used to rescue the CMV-EGFP insert from the HVP-2 vhs gene. HVP-2⌬vhs DNA was cotransfected into Vero cells with pBam20. Plaques that did not exhibit EGFP expression using fluorescent microscopy were identified, picked, and subsequently plaque-purified three times. The resulting virus was designated HVP2⌬vhsR and was grown to high titer on Vero cells. The identity of the respective viruses was confirmed relative to wild-type virus by Southern analysis using probes specific for the vhs homolog and EGFP genes.
Characterization of HVP-2⌬vhs growth in vitro
Plaque morphology was assessed on Vero cells with an overlay of DMEM/5% fetal calf serum/1% methyl cellulose at 2-3 days postinfection. Plaques were visualized on an Olympus CK2 microscope. Single-step growth curves were performed in duplicate on Vero cells. Briefly, 1 ϫ 10 5 cells in 24-well dishes (Falcon) were inoculated with two plaque forming units per cell of wild-type or mutant virus in 200 l of media and incubated at 37°C for 1 h. The infectious inoculum was aspirated and replaced with 1 ml of complete growth media (DMEM with 10% fetal bovine serum). At varying times postinfection samples were frozen at Ϫ70°C. Samples were thawed quickly to release infectious virus and subjected to a low-speed centrifugation to remove cellular debris. Aliquots of cleared supernatant were assayed for the presence of infectious virus by standard plaque assay on Vero cells. Determination of burst size (number of plaque forming units released per plaque) was determined on Vero cells and primary baboon fibroblasts. Briefly, cells were infected in quadruplicate on six-well dishes with increasing dilutions of virus. The virus was allowed to adhere for 1 h at 37°C. The inoculum was removed and replaced with complete growth medium (two wells) or growth medium plus methyl cellulose (two wells). After plaques were fully formed at 3-4 days postinfection, the number of plaques per well was determined from the samples containing the methyl cellulose overlay. The corresponding plates under DMEM were frozen and thawed, and the debris was pelleted by low-speed centrifugation. The number of plaque forming units in the supernatant was determined by standard plaque assay on Vero cells. The number of plaque forming units per original plaque was determined by comparing the yield with the number of plaques counted for the respective dilution relative to the number of plaques originally counted on the first series of dilutions plated under methyl cellulose.
